nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—AKR1C3—uterine cancer	0.455	1	CbGaD
Meclofenamic acid—AKR1C3—Medroxyprogesterone Acetate—uterine cancer	0.336	0.775	CbGbCtD
Meclofenamic acid—AKR1C3—Doxorubicin—uterine cancer	0.0679	0.157	CbGbCtD
Meclofenamic acid—PTGS2—Etoposide—uterine cancer	0.0162	0.0373	CbGbCtD
Meclofenamic acid—PTGS1—Etoposide—uterine cancer	0.0136	0.0315	CbGbCtD
Meclofenamic acid—Erythema nodosum—Progesterone—uterine cancer	0.00206	0.0446	CcSEcCtD
Meclofenamic acid—AKR1C3—Podofilox—Etoposide—uterine cancer	0.00194	1	CbGdCrCtD
Meclofenamic acid—Erythema nodosum—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.0404	CcSEcCtD
Meclofenamic acid—PTGS1—oviduct—uterine cancer	0.00147	0.0533	CbGeAlD
Meclofenamic acid—AKR1C3—myometrium—uterine cancer	0.00133	0.0482	CbGeAlD
Meclofenamic acid—KCNQ3—female reproductive system—uterine cancer	0.00132	0.0478	CbGeAlD
Meclofenamic acid—KCNQ2—female reproductive system—uterine cancer	0.00121	0.044	CbGeAlD
Meclofenamic acid—KCNQ2—female gonad—uterine cancer	0.0011	0.04	CbGeAlD
Meclofenamic acid—Mefenamic acid—AKR1C1—uterine cancer	0.00107	0.243	CrCbGaD
Meclofenamic acid—SLCO1C1—renal system—uterine cancer	0.00105	0.0382	CbGeAlD
Meclofenamic acid—Acetylsalicylic acid—AKR1C1—uterine cancer	0.00105	0.237	CrCbGaD
Meclofenamic acid—AKR1C3—uterine cervix—uterine cancer	0.00103	0.0375	CbGeAlD
Meclofenamic acid—Jaundice cholestatic—Progesterone—uterine cancer	0.00101	0.0219	CcSEcCtD
Meclofenamic acid—AKR1C3—smooth muscle tissue—uterine cancer	0.00101	0.0365	CbGeAlD
Meclofenamic acid—AKR1C3—decidua—uterine cancer	0.000985	0.0357	CbGeAlD
Meclofenamic acid—PTGS1—artery—uterine cancer	0.000973	0.0353	CbGeAlD
Meclofenamic acid—Nocturia—Progesterone—uterine cancer	0.00096	0.0208	CcSEcCtD
Meclofenamic acid—AKR1C3—endometrium—uterine cancer	0.000935	0.0339	CbGeAlD
Meclofenamic acid—PTGS2—artery—uterine cancer	0.00093	0.0337	CbGeAlD
Meclofenamic acid—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.000919	0.0199	CcSEcCtD
Meclofenamic acid—AKR1C3—mammalian vulva—uterine cancer	0.000905	0.0328	CbGeAlD
Meclofenamic acid—ALOX5—smooth muscle tissue—uterine cancer	0.000886	0.0321	CbGeAlD
Meclofenamic acid—ALOX5—decidua—uterine cancer	0.000869	0.0315	CbGeAlD
Meclofenamic acid—AKR1C3—uterus—uterine cancer	0.000862	0.0313	CbGeAlD
Meclofenamic acid—Salicylic acid—AKR1C1—uterine cancer	0.000861	0.195	CrCbGaD
Meclofenamic acid—Ulcer—Medroxyprogesterone Acetate—uterine cancer	0.000853	0.0185	CcSEcCtD
Meclofenamic acid—AKR1C3—female gonad—uterine cancer	0.000705	0.0256	CbGeAlD
Meclofenamic acid—AKR1C3—vagina—uterine cancer	0.000701	0.0254	CbGeAlD
Meclofenamic acid—ALOX5—female reproductive system—uterine cancer	0.000683	0.0248	CbGeAlD
Meclofenamic acid—Ulcer—Dactinomycin—uterine cancer	0.000666	0.0144	CcSEcCtD
Meclofenamic acid—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000649	0.014	CcSEcCtD
Meclofenamic acid—Mefenamic acid—AKR1C3—uterine cancer	0.000623	0.141	CrCbGaD
Meclofenamic acid—ALOX5—female gonad—uterine cancer	0.000622	0.0225	CbGeAlD
Meclofenamic acid—Erythema nodosum—Epirubicin—uterine cancer	0.000591	0.0128	CcSEcCtD
Meclofenamic acid—Erythema nodosum—Doxorubicin—uterine cancer	0.000547	0.0118	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—TP53—uterine cancer	0.000545	0.123	CrCbGaD
Meclofenamic acid—SLCO1C1—lymph node—uterine cancer	0.000493	0.0179	CbGeAlD
Meclofenamic acid—Conjunctivitis—Progesterone—uterine cancer	0.000484	0.0105	CcSEcCtD
Meclofenamic acid—Ulcer—Etoposide—uterine cancer	0.000482	0.0104	CcSEcCtD
Meclofenamic acid—Blindness—Epirubicin—uterine cancer	0.000461	0.00998	CcSEcCtD
Meclofenamic acid—AKR1C3—lymph node—uterine cancer	0.000453	0.0164	CbGeAlD
Meclofenamic acid—Haemoglobin—Progesterone—uterine cancer	0.00045	0.00973	CcSEcCtD
Meclofenamic acid—PTGS2—myometrium—uterine cancer	0.000449	0.0163	CbGeAlD
Meclofenamic acid—Haemorrhage—Progesterone—uterine cancer	0.000447	0.00968	CcSEcCtD
Meclofenamic acid—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00044	0.00953	CcSEcCtD
Meclofenamic acid—Blindness—Doxorubicin—uterine cancer	0.000427	0.00924	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Progesterone—uterine cancer	0.000423	0.00915	CcSEcCtD
Meclofenamic acid—Tinnitus—Progesterone—uterine cancer	0.000417	0.00903	CcSEcCtD
Meclofenamic acid—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000407	0.00882	CcSEcCtD
Meclofenamic acid—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000405	0.00877	CcSEcCtD
Meclofenamic acid—ALOX5—lymph node—uterine cancer	0.0004	0.0145	CbGeAlD
Meclofenamic acid—Alopecia—Progesterone—uterine cancer	0.000395	0.00856	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.000383	0.00829	CcSEcCtD
Meclofenamic acid—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.000378	0.00818	CcSEcCtD
Meclofenamic acid—Neutropenia—Dactinomycin—uterine cancer	0.000369	0.00799	CcSEcCtD
Meclofenamic acid—PTGS1—epithelium—uterine cancer	0.000369	0.0134	CbGeAlD
Meclofenamic acid—Vision blurred—Progesterone—uterine cancer	0.000367	0.00794	CcSEcCtD
Meclofenamic acid—PTGS1—uterine cervix—uterine cancer	0.000366	0.0133	CbGeAlD
Meclofenamic acid—Ill-defined disorder—Progesterone—uterine cancer	0.000361	0.00782	CcSEcCtD
Meclofenamic acid—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000358	0.00775	CcSEcCtD
Meclofenamic acid—PTGS1—smooth muscle tissue—uterine cancer	0.000356	0.0129	CbGeAlD
Meclofenamic acid—PTGS2—epithelium—uterine cancer	0.000353	0.0128	CbGeAlD
Meclofenamic acid—Malaise—Progesterone—uterine cancer	0.000351	0.0076	CcSEcCtD
Meclofenamic acid—PTGS2—uterine cervix—uterine cancer	0.00035	0.0127	CbGeAlD
Meclofenamic acid—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.000349	0.00756	CcSEcCtD
Meclofenamic acid—Palpitations—Progesterone—uterine cancer	0.000344	0.00745	CcSEcCtD
Meclofenamic acid—Stomatitis—Dactinomycin—uterine cancer	0.000343	0.00743	CcSEcCtD
Meclofenamic acid—PTGS1—renal system—uterine cancer	0.000342	0.0124	CbGeAlD
Meclofenamic acid—PTGS2—smooth muscle tissue—uterine cancer	0.00034	0.0123	CbGeAlD
Meclofenamic acid—PTGS1—endometrium—uterine cancer	0.000331	0.012	CbGeAlD
Meclofenamic acid—Agranulocytosis—Dactinomycin—uterine cancer	0.000329	0.00711	CcSEcCtD
Meclofenamic acid—Discomfort—Progesterone—uterine cancer	0.000328	0.00709	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000327	0.00709	CcSEcCtD
Meclofenamic acid—PTGS2—renal system—uterine cancer	0.000327	0.0119	CbGeAlD
Meclofenamic acid—PTGS1—mammalian vulva—uterine cancer	0.00032	0.0116	CbGeAlD
Meclofenamic acid—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000318	0.00689	CcSEcCtD
Meclofenamic acid—Oedema—Progesterone—uterine cancer	0.000318	0.00688	CcSEcCtD
Meclofenamic acid—PTGS2—endometrium—uterine cancer	0.000316	0.0115	CbGeAlD
Meclofenamic acid—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000312	0.00675	CcSEcCtD
Meclofenamic acid—PTGS1—uterus—uterine cancer	0.000305	0.0111	CbGeAlD
Meclofenamic acid—Anorexia—Progesterone—uterine cancer	0.000303	0.00656	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Dactinomycin—uterine cancer	0.000299	0.00647	CcSEcCtD
Meclofenamic acid—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000297	0.00642	CcSEcCtD
Meclofenamic acid—PTGS2—uterus—uterine cancer	0.000292	0.0106	CbGeAlD
Meclofenamic acid—Jaundice cholestatic—Epirubicin—uterine cancer	0.000291	0.00629	CcSEcCtD
Meclofenamic acid—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000288	0.00623	CcSEcCtD
Meclofenamic acid—Insomnia—Progesterone—uterine cancer	0.000287	0.00622	CcSEcCtD
Meclofenamic acid—Paraesthesia—Progesterone—uterine cancer	0.000285	0.00618	CcSEcCtD
Meclofenamic acid—Alopecia—Dactinomycin—uterine cancer	0.000279	0.00605	CcSEcCtD
Meclofenamic acid—Decreased appetite—Progesterone—uterine cancer	0.000276	0.00598	CcSEcCtD
Meclofenamic acid—Nocturia—Epirubicin—uterine cancer	0.000275	0.00596	CcSEcCtD
Meclofenamic acid—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000275	0.00594	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Progesterone—uterine cancer	0.000274	0.00594	CcSEcCtD
Meclofenamic acid—PTGS1—female reproductive system—uterine cancer	0.000274	0.00995	CbGeAlD
Meclofenamic acid—Fatigue—Progesterone—uterine cancer	0.000274	0.00593	CcSEcCtD
Meclofenamic acid—Constipation—Progesterone—uterine cancer	0.000272	0.00588	CcSEcCtD
Meclofenamic acid—Ulcer—Epirubicin—uterine cancer	0.00027	0.00584	CcSEcCtD
Meclofenamic acid—Diclofenac—CXCL8—uterine cancer	0.000269	0.0609	CrCbGaD
Meclofenamic acid—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000269	0.00582	CcSEcCtD
Meclofenamic acid—Neutropenia—Etoposide—uterine cancer	0.000267	0.00579	CcSEcCtD
Meclofenamic acid—PTGS2—female reproductive system—uterine cancer	0.000262	0.00951	CbGeAlD
Meclofenamic acid—Feeling abnormal—Progesterone—uterine cancer	0.000262	0.00567	CcSEcCtD
Meclofenamic acid—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000261	0.00564	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Progesterone—uterine cancer	0.00026	0.00562	CcSEcCtD
Meclofenamic acid—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000259	0.0056	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Dactinomycin—uterine cancer	0.000255	0.00553	CcSEcCtD
Meclofenamic acid—Nocturia—Doxorubicin—uterine cancer	0.000255	0.00551	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000253	0.00547	CcSEcCtD
Meclofenamic acid—Urticaria—Progesterone—uterine cancer	0.000253	0.00546	CcSEcCtD
Meclofenamic acid—Abdominal pain—Progesterone—uterine cancer	0.000251	0.00544	CcSEcCtD
Meclofenamic acid—Renal failure—Etoposide—uterine cancer	0.000251	0.00542	CcSEcCtD
Meclofenamic acid—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00025	0.00542	CcSEcCtD
Meclofenamic acid—Ulcer—Doxorubicin—uterine cancer	0.00025	0.00541	CcSEcCtD
Meclofenamic acid—PTGS1—female gonad—uterine cancer	0.000249	0.00905	CbGeAlD
Meclofenamic acid—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000249	0.00538	CcSEcCtD
Meclofenamic acid—Stomatitis—Etoposide—uterine cancer	0.000249	0.00538	CcSEcCtD
Meclofenamic acid—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000248	0.00537	CcSEcCtD
Meclofenamic acid—Malaise—Dactinomycin—uterine cancer	0.000248	0.00537	CcSEcCtD
Meclofenamic acid—PTGS1—vagina—uterine cancer	0.000248	0.009	CbGeAlD
Meclofenamic acid—Leukopenia—Dactinomycin—uterine cancer	0.000246	0.00533	CcSEcCtD
Meclofenamic acid—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000246	0.00533	CcSEcCtD
Meclofenamic acid—Colitis—Epirubicin—uterine cancer	0.000245	0.00531	CcSEcCtD
Meclofenamic acid—PTGS2—female gonad—uterine cancer	0.000238	0.00865	CbGeAlD
Meclofenamic acid—Agranulocytosis—Etoposide—uterine cancer	0.000238	0.00515	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000237	0.00514	CcSEcCtD
Meclofenamic acid—PTGS2—vagina—uterine cancer	0.000237	0.0086	CbGeAlD
Meclofenamic acid—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000236	0.0051	CcSEcCtD
Meclofenamic acid—Discomfort—Dactinomycin—uterine cancer	0.000232	0.00501	CcSEcCtD
Meclofenamic acid—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000229	0.00495	CcSEcCtD
Meclofenamic acid—Asthenia—Progesterone—uterine cancer	0.000228	0.00493	CcSEcCtD
Meclofenamic acid—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000228	0.00493	CcSEcCtD
Meclofenamic acid—Colitis—Doxorubicin—uterine cancer	0.000227	0.00491	CcSEcCtD
Meclofenamic acid—Pruritus—Progesterone—uterine cancer	0.000225	0.00487	CcSEcCtD
Meclofenamic acid—Oedema—Dactinomycin—uterine cancer	0.000225	0.00486	CcSEcCtD
Meclofenamic acid—Diarrhoea—Progesterone—uterine cancer	0.000217	0.00471	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Etoposide—uterine cancer	0.000216	0.00468	CcSEcCtD
Meclofenamic acid—Anorexia—Dactinomycin—uterine cancer	0.000214	0.00463	CcSEcCtD
Meclofenamic acid—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000207	0.00447	CcSEcCtD
Meclofenamic acid—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000204	0.00441	CcSEcCtD
Meclofenamic acid—Alopecia—Etoposide—uterine cancer	0.000202	0.00438	CcSEcCtD
Meclofenamic acid—Vomiting—Progesterone—uterine cancer	0.000202	0.00437	CcSEcCtD
Meclofenamic acid—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.00426	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000197	0.00425	CcSEcCtD
Meclofenamic acid—Decreased appetite—Dactinomycin—uterine cancer	0.000195	0.00423	CcSEcCtD
Meclofenamic acid—Fatigue—Dactinomycin—uterine cancer	0.000194	0.00419	CcSEcCtD
Meclofenamic acid—Nausea—Progesterone—uterine cancer	0.000189	0.00409	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Dactinomycin—uterine cancer	0.000185	0.00401	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Etoposide—uterine cancer	0.000185	0.004	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000184	0.00398	CcSEcCtD
Meclofenamic acid—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000183	0.00396	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000182	0.00394	CcSEcCtD
Meclofenamic acid—Malaise—Etoposide—uterine cancer	0.00018	0.00389	CcSEcCtD
Meclofenamic acid—Leukopenia—Etoposide—uterine cancer	0.000178	0.00386	CcSEcCtD
Meclofenamic acid—Abdominal pain—Dactinomycin—uterine cancer	0.000178	0.00384	CcSEcCtD
Meclofenamic acid—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000171	0.0037	CcSEcCtD
Meclofenamic acid—Discomfort—Etoposide—uterine cancer	0.000168	0.00363	CcSEcCtD
Meclofenamic acid—Asthenia—Dactinomycin—uterine cancer	0.000161	0.00349	CcSEcCtD
Meclofenamic acid—PTGS1—lymph node—uterine cancer	0.00016	0.00582	CbGeAlD
Meclofenamic acid—Eosinophilia—Epirubicin—uterine cancer	0.000159	0.00343	CcSEcCtD
Meclofenamic acid—Anorexia—Etoposide—uterine cancer	0.000155	0.00335	CcSEcCtD
Meclofenamic acid—Diarrhoea—Dactinomycin—uterine cancer	0.000154	0.00333	CcSEcCtD
Meclofenamic acid—PTGS2—lymph node—uterine cancer	0.000153	0.00556	CbGeAlD
Meclofenamic acid—Neutropenia—Epirubicin—uterine cancer	0.00015	0.00324	CcSEcCtD
Meclofenamic acid—Eosinophilia—Doxorubicin—uterine cancer	0.000147	0.00318	CcSEcCtD
Meclofenamic acid—Paraesthesia—Etoposide—uterine cancer	0.000146	0.00316	CcSEcCtD
Meclofenamic acid—Vomiting—Dactinomycin—uterine cancer	0.000143	0.00309	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000142	0.00307	CcSEcCtD
Meclofenamic acid—Decreased appetite—Etoposide—uterine cancer	0.000141	0.00306	CcSEcCtD
Meclofenamic acid—Renal failure—Epirubicin—uterine cancer	0.00014	0.00304	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Etoposide—uterine cancer	0.00014	0.00304	CcSEcCtD
Meclofenamic acid—Fatigue—Etoposide—uterine cancer	0.00014	0.00303	CcSEcCtD
Meclofenamic acid—Stomatitis—Epirubicin—uterine cancer	0.000139	0.00301	CcSEcCtD
Meclofenamic acid—Constipation—Etoposide—uterine cancer	0.000139	0.00301	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Epirubicin—uterine cancer	0.000139	0.00301	CcSEcCtD
Meclofenamic acid—Neutropenia—Doxorubicin—uterine cancer	0.000139	0.003	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Etoposide—uterine cancer	0.000134	0.0029	CcSEcCtD
Meclofenamic acid—Nausea—Dactinomycin—uterine cancer	0.000133	0.00289	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Epirubicin—uterine cancer	0.000133	0.00289	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Etoposide—uterine cancer	0.000133	0.00288	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000131	0.00284	CcSEcCtD
Meclofenamic acid—Renal failure—Doxorubicin—uterine cancer	0.00013	0.00281	CcSEcCtD
Meclofenamic acid—Urticaria—Etoposide—uterine cancer	0.000129	0.0028	CcSEcCtD
Meclofenamic acid—Haemoglobin—Epirubicin—uterine cancer	0.000129	0.00279	CcSEcCtD
Meclofenamic acid—Stomatitis—Doxorubicin—uterine cancer	0.000129	0.00279	CcSEcCtD
Meclofenamic acid—Abdominal pain—Etoposide—uterine cancer	0.000129	0.00278	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Doxorubicin—uterine cancer	0.000129	0.00278	CcSEcCtD
Meclofenamic acid—Haemorrhage—Epirubicin—uterine cancer	0.000128	0.00278	CcSEcCtD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—GPX3—uterine cancer	0.000125	0.00401	CbGpPWpGaD
Meclofenamic acid—Agranulocytosis—Doxorubicin—uterine cancer	0.000123	0.00267	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Epirubicin—uterine cancer	0.000121	0.00262	CcSEcCtD
Meclofenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—uterine cancer	0.00012	0.00383	CbGpPWpGaD
Meclofenamic acid—Tinnitus—Epirubicin—uterine cancer	0.00012	0.00259	CcSEcCtD
Meclofenamic acid—Haemoglobin—Doxorubicin—uterine cancer	0.000119	0.00258	CcSEcCtD
Meclofenamic acid—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000119	0.0038	CbGpPWpGaD
Meclofenamic acid—Haemorrhage—Doxorubicin—uterine cancer	0.000119	0.00257	CcSEcCtD
Meclofenamic acid—Asthenia—Etoposide—uterine cancer	0.000117	0.00252	CcSEcCtD
Meclofenamic acid—Pruritus—Etoposide—uterine cancer	0.000115	0.00249	CcSEcCtD
Meclofenamic acid—Alopecia—Epirubicin—uterine cancer	0.000113	0.00245	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Doxorubicin—uterine cancer	0.000112	0.00243	CcSEcCtD
Meclofenamic acid—Diarrhoea—Etoposide—uterine cancer	0.000111	0.00241	CcSEcCtD
Meclofenamic acid—Tinnitus—Doxorubicin—uterine cancer	0.000111	0.00239	CcSEcCtD
Meclofenamic acid—PTGS2—S1P1 pathway—VEGFA—uterine cancer	0.00011	0.00353	CbGpPWpGaD
Meclofenamic acid—Vision blurred—Epirubicin—uterine cancer	0.000105	0.00228	CcSEcCtD
Meclofenamic acid—Alopecia—Doxorubicin—uterine cancer	0.000105	0.00227	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Epirubicin—uterine cancer	0.000104	0.00224	CcSEcCtD
Meclofenamic acid—Vomiting—Etoposide—uterine cancer	0.000103	0.00224	CcSEcCtD
Meclofenamic acid—Malaise—Epirubicin—uterine cancer	0.000101	0.00218	CcSEcCtD
Meclofenamic acid—Leukopenia—Epirubicin—uterine cancer	0.0001	0.00216	CcSEcCtD
Meclofenamic acid—Palpitations—Epirubicin—uterine cancer	9.87e-05	0.00214	CcSEcCtD
Meclofenamic acid—Vision blurred—Doxorubicin—uterine cancer	9.74e-05	0.00211	CcSEcCtD
Meclofenamic acid—Nausea—Etoposide—uterine cancer	9.66e-05	0.00209	CcSEcCtD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	9.62e-05	0.00308	CbGpPWpGaD
Meclofenamic acid—Ill-defined disorder—Doxorubicin—uterine cancer	9.59e-05	0.00207	CcSEcCtD
Meclofenamic acid—Discomfort—Epirubicin—uterine cancer	9.39e-05	0.00203	CcSEcCtD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.32e-05	0.00298	CbGpPWpGaD
Meclofenamic acid—Malaise—Doxorubicin—uterine cancer	9.32e-05	0.00202	CcSEcCtD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.29e-05	0.00297	CbGpPWpGaD
Meclofenamic acid—Leukopenia—Doxorubicin—uterine cancer	9.25e-05	0.002	CcSEcCtD
Meclofenamic acid—Palpitations—Doxorubicin—uterine cancer	9.13e-05	0.00198	CcSEcCtD
Meclofenamic acid—Oedema—Epirubicin—uterine cancer	9.11e-05	0.00197	CcSEcCtD
Meclofenamic acid—Discomfort—Doxorubicin—uterine cancer	8.69e-05	0.00188	CcSEcCtD
Meclofenamic acid—Anorexia—Epirubicin—uterine cancer	8.69e-05	0.00188	CcSEcCtD
Meclofenamic acid—PTGS1—Biological oxidations—CYP11A1—uterine cancer	8.58e-05	0.00275	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	8.54e-05	0.00273	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—MET—uterine cancer	8.46e-05	0.00271	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—MET—uterine cancer	8.46e-05	0.00271	CbGpPWpGaD
Meclofenamic acid—Oedema—Doxorubicin—uterine cancer	8.43e-05	0.00182	CcSEcCtD
Meclofenamic acid—Insomnia—Epirubicin—uterine cancer	8.24e-05	0.00178	CcSEcCtD
Meclofenamic acid—Paraesthesia—Epirubicin—uterine cancer	8.18e-05	0.00177	CcSEcCtD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—MTHFR—uterine cancer	8.11e-05	0.00259	CbGpPWpGaD
Meclofenamic acid—Anorexia—Doxorubicin—uterine cancer	8.04e-05	0.00174	CcSEcCtD
Meclofenamic acid—Decreased appetite—Epirubicin—uterine cancer	7.92e-05	0.00171	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Epirubicin—uterine cancer	7.87e-05	0.0017	CcSEcCtD
Meclofenamic acid—Fatigue—Epirubicin—uterine cancer	7.86e-05	0.0017	CcSEcCtD
Meclofenamic acid—ALOX5—Metabolism—NDUFB11—uterine cancer	7.82e-05	0.0025	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—SRD5A2—uterine cancer	7.82e-05	0.0025	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—NDUFB11—uterine cancer	7.79e-05	0.00249	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—SRD5A2—uterine cancer	7.79e-05	0.00249	CbGpPWpGaD
Meclofenamic acid—Constipation—Epirubicin—uterine cancer	7.79e-05	0.00169	CcSEcCtD
Meclofenamic acid—Insomnia—Doxorubicin—uterine cancer	7.63e-05	0.00165	CcSEcCtD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.62e-05	0.00244	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.6e-05	0.00243	CbGpPWpGaD
Meclofenamic acid—Paraesthesia—Doxorubicin—uterine cancer	7.57e-05	0.00164	CcSEcCtD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.57e-05	0.00242	CbGpPWpGaD
Meclofenamic acid—Feeling abnormal—Epirubicin—uterine cancer	7.51e-05	0.00163	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Epirubicin—uterine cancer	7.45e-05	0.00161	CcSEcCtD
Meclofenamic acid—KCNQ3—Developmental Biology—SMAD3—uterine cancer	7.37e-05	0.00236	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—SMAD3—uterine cancer	7.37e-05	0.00236	CbGpPWpGaD
Meclofenamic acid—Decreased appetite—Doxorubicin—uterine cancer	7.33e-05	0.00159	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Doxorubicin—uterine cancer	7.28e-05	0.00158	CcSEcCtD
Meclofenamic acid—Fatigue—Doxorubicin—uterine cancer	7.27e-05	0.00157	CcSEcCtD
Meclofenamic acid—Urticaria—Epirubicin—uterine cancer	7.24e-05	0.00157	CcSEcCtD
Meclofenamic acid—AKR1C3—Disease—AKR1B10—uterine cancer	7.24e-05	0.00232	CbGpPWpGaD
Meclofenamic acid—Constipation—Doxorubicin—uterine cancer	7.21e-05	0.00156	CcSEcCtD
Meclofenamic acid—Abdominal pain—Epirubicin—uterine cancer	7.21e-05	0.00156	CcSEcCtD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.18e-05	0.0023	CbGpPWpGaD
Meclofenamic acid—Feeling abnormal—Doxorubicin—uterine cancer	6.95e-05	0.0015	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Doxorubicin—uterine cancer	6.9e-05	0.00149	CcSEcCtD
Meclofenamic acid—Urticaria—Doxorubicin—uterine cancer	6.7e-05	0.00145	CcSEcCtD
Meclofenamic acid—Abdominal pain—Doxorubicin—uterine cancer	6.67e-05	0.00144	CcSEcCtD
Meclofenamic acid—Asthenia—Epirubicin—uterine cancer	6.54e-05	0.00142	CcSEcCtD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	6.54e-05	0.00209	CbGpPWpGaD
Meclofenamic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	6.5e-05	0.00208	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—ABCC9—uterine cancer	6.47e-05	0.00207	CbGpPWpGaD
Meclofenamic acid—Pruritus—Epirubicin—uterine cancer	6.45e-05	0.0014	CcSEcCtD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—MTHFR—uterine cancer	6.44e-05	0.00206	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—CCL2—uterine cancer	6.35e-05	0.00203	CbGpPWpGaD
Meclofenamic acid—PTGS1—Biological oxidations—CYP19A1—uterine cancer	6.31e-05	0.00202	CbGpPWpGaD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—uterine cancer	6.26e-05	0.002	CbGpPWpGaD
Meclofenamic acid—Diarrhoea—Epirubicin—uterine cancer	6.24e-05	0.00135	CcSEcCtD
Meclofenamic acid—KCNQ2—Axon guidance—ERBB2—uterine cancer	6.18e-05	0.00198	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—ERBB2—uterine cancer	6.18e-05	0.00198	CbGpPWpGaD
Meclofenamic acid—Asthenia—Doxorubicin—uterine cancer	6.05e-05	0.00131	CcSEcCtD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.05e-05	0.00193	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—MET—uterine cancer	6.04e-05	0.00193	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—MET—uterine cancer	6.04e-05	0.00193	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—RNF43—uterine cancer	6e-05	0.00192	CbGpPWpGaD
Meclofenamic acid—Pruritus—Doxorubicin—uterine cancer	5.97e-05	0.00129	CcSEcCtD
Meclofenamic acid—Vomiting—Epirubicin—uterine cancer	5.8e-05	0.00125	CcSEcCtD
Meclofenamic acid—Diarrhoea—Doxorubicin—uterine cancer	5.77e-05	0.00125	CcSEcCtD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	5.74e-05	0.00184	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AKR1B1—uterine cancer	5.66e-05	0.00181	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—STAR—uterine cancer	5.66e-05	0.00181	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—STAR—uterine cancer	5.64e-05	0.0018	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AKR1B1—uterine cancer	5.64e-05	0.0018	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.59e-05	0.00179	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.57e-05	0.00178	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.51e-05	0.00176	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.51e-05	0.00176	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	5.48e-05	0.00175	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	5.44e-05	0.00174	CbGpPWpGaD
Meclofenamic acid—Nausea—Epirubicin—uterine cancer	5.41e-05	0.00117	CcSEcCtD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	5.37e-05	0.00172	CbGpPWpGaD
Meclofenamic acid—Vomiting—Doxorubicin—uterine cancer	5.36e-05	0.00116	CcSEcCtD
Meclofenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	5.11e-05	0.00164	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	5.08e-05	0.00162	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKR1B10—uterine cancer	5.07e-05	0.00162	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—CCL2—uterine cancer	5.04e-05	0.00161	CbGpPWpGaD
Meclofenamic acid—Nausea—Doxorubicin—uterine cancer	5.01e-05	0.00108	CcSEcCtD
Meclofenamic acid—AKR1C3—Disease—AKR1C1—uterine cancer	4.94e-05	0.00158	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—VEGFA—uterine cancer	4.76e-05	0.00152	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—VEGFA—uterine cancer	4.76e-05	0.00152	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—NRAS—uterine cancer	4.7e-05	0.0015	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—NRAS—uterine cancer	4.7e-05	0.0015	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	4.62e-05	0.00148	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	4.61e-05	0.00147	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—CDKN2A—uterine cancer	4.56e-05	0.00146	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—POLD1—uterine cancer	4.44e-05	0.00142	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—POLD1—uterine cancer	4.42e-05	0.00141	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—ERBB2—uterine cancer	4.41e-05	0.00141	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—ERBB2—uterine cancer	4.41e-05	0.00141	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.37e-05	0.0014	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.37e-05	0.0014	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—DCN—uterine cancer	4.27e-05	0.00137	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RNF43—uterine cancer	4.2e-05	0.00134	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AKR1C1—uterine cancer	4.15e-05	0.00133	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AKR1C1—uterine cancer	4.14e-05	0.00132	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	4.13e-05	0.00132	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—KRAS—uterine cancer	4.05e-05	0.00129	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—KRAS—uterine cancer	4.05e-05	0.00129	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.04e-05	0.00129	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	4.04e-05	0.00129	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	3.98e-05	0.00127	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	3.93e-05	0.00126	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Neuronal System—HRAS—uterine cancer	3.88e-05	0.00124	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Neuronal System—HRAS—uterine cancer	3.88e-05	0.00124	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—CTNNB1—uterine cancer	3.86e-05	0.00123	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—CTNNB1—uterine cancer	3.86e-05	0.00123	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—INHBA—uterine cancer	3.84e-05	0.00123	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HMGA1—uterine cancer	3.71e-05	0.00119	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—RRM2—uterine cancer	3.7e-05	0.00118	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—RRM2—uterine cancer	3.69e-05	0.00118	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—DCN—uterine cancer	3.59e-05	0.00115	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—EP300—uterine cancer	3.59e-05	0.00115	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—EP300—uterine cancer	3.59e-05	0.00115	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—DCN—uterine cancer	3.58e-05	0.00114	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	3.55e-05	0.00113	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKR1C1—uterine cancer	3.46e-05	0.00111	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—HRAS—uterine cancer	3.44e-05	0.0011	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—HRAS—uterine cancer	3.44e-05	0.0011	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—VEGFA—uterine cancer	3.4e-05	0.00109	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—VEGFA—uterine cancer	3.4e-05	0.00109	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NDUFB11—uterine cancer	3.39e-05	0.00109	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SRD5A2—uterine cancer	3.39e-05	0.00109	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—FBXW7—uterine cancer	3.39e-05	0.00108	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CYP11A1—uterine cancer	3.38e-05	0.00108	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CYP11A1—uterine cancer	3.37e-05	0.00108	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—NRAS—uterine cancer	3.36e-05	0.00107	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—NRAS—uterine cancer	3.36e-05	0.00107	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	3.32e-05	0.00106	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.3e-05	0.00105	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.21e-05	0.00103	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AKR1C3—uterine cancer	3.2e-05	0.00102	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	3.15e-05	0.00101	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.11e-05	0.000996	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	3.08e-05	0.000985	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	3.08e-05	0.000984	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—KRAS—uterine cancer	2.89e-05	0.000924	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—KRAS—uterine cancer	2.89e-05	0.000924	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	2.85e-05	0.000913	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NDUFB11—uterine cancer	2.69e-05	0.000862	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SRD5A2—uterine cancer	2.69e-05	0.000862	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN2B—uterine cancer	2.66e-05	0.000849	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.62e-05	0.000837	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PGR—uterine cancer	2.59e-05	0.00083	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKR1B10—uterine cancer	2.5e-05	0.0008	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—STK11—uterine cancer	2.49e-05	0.000797	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CYP19A1—uterine cancer	2.49e-05	0.000797	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—STK11—uterine cancer	2.48e-05	0.000794	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CYP19A1—uterine cancer	2.48e-05	0.000794	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—YWHAE—uterine cancer	2.48e-05	0.000792	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.47e-05	0.00079	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—HRAS—uterine cancer	2.46e-05	0.000785	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—HRAS—uterine cancer	2.46e-05	0.000785	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKR1B1—uterine cancer	2.45e-05	0.000785	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—STAR—uterine cancer	2.45e-05	0.000785	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	2.43e-05	0.000776	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.42e-05	0.000776	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SMAD3—uterine cancer	2.42e-05	0.000776	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—FBXW7—uterine cancer	2.37e-05	0.000759	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.34e-05	0.000748	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.33e-05	0.000745	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—FGFR2—uterine cancer	2.31e-05	0.00074	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.26e-05	0.000723	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.23e-05	0.000713	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MTHFR—uterine cancer	2.23e-05	0.000712	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.22e-05	0.00071	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—AKT1—uterine cancer	2.17e-05	0.000693	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—AKT1—uterine cancer	2.17e-05	0.000693	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.09e-05	0.000669	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—STK11—uterine cancer	2.07e-05	0.000664	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RNF43—uterine cancer	2.07e-05	0.000663	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.98e-05	0.000632	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKR1B1—uterine cancer	1.95e-05	0.000623	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—STAR—uterine cancer	1.95e-05	0.000623	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SOCS3—uterine cancer	1.94e-05	0.000621	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TP53—uterine cancer	1.93e-05	0.000618	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.93e-05	0.000616	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—POLD1—uterine cancer	1.92e-05	0.000616	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.92e-05	0.000616	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—MTHFR—uterine cancer	1.87e-05	0.000599	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—MTHFR—uterine cancer	1.86e-05	0.000596	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN2B—uterine cancer	1.86e-05	0.000595	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.84e-05	0.000588	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IGF1R—uterine cancer	1.81e-05	0.000578	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKR1C1—uterine cancer	1.8e-05	0.000576	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.74e-05	0.000557	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKR1C1—uterine cancer	1.71e-05	0.000546	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SMAD3—uterine cancer	1.7e-05	0.000543	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.65e-05	0.000528	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.64e-05	0.000526	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—FGFR2—uterine cancer	1.62e-05	0.000518	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—RRM2—uterine cancer	1.6e-05	0.000513	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—DCN—uterine cancer	1.56e-05	0.000498	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—POLD1—uterine cancer	1.53e-05	0.000489	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.48e-05	0.000473	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—DCN—uterine cancer	1.48e-05	0.000472	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP11A1—uterine cancer	1.47e-05	0.000469	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—ERBB2—uterine cancer	1.45e-05	0.000465	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKR1C1—uterine cancer	1.43e-05	0.000457	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKR1C3—uterine cancer	1.39e-05	0.000443	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ESR1—uterine cancer	1.39e-05	0.000443	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.36e-05	0.000435	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1B—uterine cancer	1.34e-05	0.00043	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.32e-05	0.000421	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKR1C3—uterine cancer	1.31e-05	0.00042	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HMGA1—uterine cancer	1.28e-05	0.00041	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—RRM2—uterine cancer	1.27e-05	0.000408	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CTNNB1—uterine cancer	1.27e-05	0.000406	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTEN—uterine cancer	1.24e-05	0.000396	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—DCN—uterine cancer	1.24e-05	0.000396	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCL2—uterine cancer	1.22e-05	0.00039	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—EP300—uterine cancer	1.18e-05	0.000378	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FBXW7—uterine cancer	1.17e-05	0.000375	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP11A1—uterine cancer	1.17e-05	0.000373	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.11e-05	0.000355	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—NRAS—uterine cancer	1.1e-05	0.000353	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKR1C3—uterine cancer	1.1e-05	0.000352	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—STK11—uterine cancer	1.08e-05	0.000345	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP19A1—uterine cancer	1.08e-05	0.000345	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTEN—uterine cancer	1.04e-05	0.000333	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTEN—uterine cancer	1.04e-05	0.000332	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ERBB2—uterine cancer	1.02e-05	0.000325	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.01e-05	0.000324	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—EP300—uterine cancer	9.93e-06	0.000318	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—EP300—uterine cancer	9.89e-06	0.000316	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.67e-06	0.000309	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CXCL8—uterine cancer	9.64e-06	0.000308	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KRAS—uterine cancer	9.51e-06	0.000304	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1B—uterine cancer	9.42e-06	0.000301	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN2B—uterine cancer	9.18e-06	0.000294	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CTNNB1—uterine cancer	8.9e-06	0.000285	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CA—uterine cancer	8.74e-06	0.000279	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTEN—uterine cancer	8.67e-06	0.000277	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—STK11—uterine cancer	8.57e-06	0.000274	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP19A1—uterine cancer	8.57e-06	0.000274	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SMAD3—uterine cancer	8.38e-06	0.000268	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EP300—uterine cancer	8.27e-06	0.000265	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—MTHFR—uterine cancer	8.11e-06	0.00026	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HRAS—uterine cancer	8.08e-06	0.000259	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.05e-06	0.000257	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGFR2—uterine cancer	7.99e-06	0.000256	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—VEGFA—uterine cancer	7.83e-06	0.000251	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NRAS—uterine cancer	7.74e-06	0.000247	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTHFR—uterine cancer	7.69e-06	0.000246	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.67e-06	0.000245	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CA—uterine cancer	7.34e-06	0.000235	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CA—uterine cancer	7.32e-06	0.000234	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.15e-06	0.000229	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—AKT1—uterine cancer	7.14e-06	0.000228	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KRAS—uterine cancer	6.66e-06	0.000213	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MTHFR—uterine cancer	6.44e-06	0.000206	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CA—uterine cancer	6.12e-06	0.000196	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AKT1—uterine cancer	6e-06	0.000192	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AKT1—uterine cancer	5.98e-06	0.000191	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TP53—uterine cancer	5.92e-06	0.000189	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.68e-06	0.000182	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HRAS—uterine cancer	5.66e-06	0.000181	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERBB2—uterine cancer	5.02e-06	0.000161	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKT1—uterine cancer	5e-06	0.00016	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1B—uterine cancer	4.65e-06	0.000149	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTEN—uterine cancer	4.51e-06	0.000144	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CTNNB1—uterine cancer	4.39e-06	0.00014	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—EP300—uterine cancer	4.31e-06	0.000138	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PTEN—uterine cancer	4.28e-06	0.000137	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EP300—uterine cancer	4.08e-06	0.000131	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NRAS—uterine cancer	3.82e-06	0.000122	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PTEN—uterine cancer	3.58e-06	0.000115	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—EP300—uterine cancer	3.42e-06	0.000109	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KRAS—uterine cancer	3.29e-06	0.000105	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CA—uterine cancer	3.18e-06	0.000102	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CA—uterine cancer	3.02e-06	9.66e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HRAS—uterine cancer	2.79e-06	8.93e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKT1—uterine cancer	2.6e-06	8.32e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CA—uterine cancer	2.53e-06	8.09e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKT1—uterine cancer	2.47e-06	7.89e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKT1—uterine cancer	2.07e-06	6.61e-05	CbGpPWpGaD
